Publications BPE group
Journal Article (5)
2025
Journal Article
354, 128769 (2025)
Streamlining the purification of a clinical-grade oncolytic virus for therapeutic applications. Separation and Purification Technology
Journal Article
109, 74 (2025)
Quantification of intracellular influenza A virus protein dynamics in different host cells after seed virus adaptation. Applied Microbiology and Biotechnology
Journal Article
102 (2), pp. 401 - 412 (2025)
Medium engineering of lipase‐catalyzed reaction usingCO2. Journal of the American Oil Chemists' Society
Journal Article
Mini-review: Application of nanoparticles in plant biotechnology and agriculture. In Vitro Cellular & Developmental Biology - Plant (2025)
Journal Article
13 (5), 1286 (2025)
Seed Train Intensification and TFDF-Based Perfusion for MDCK Cell-Based Influenza A Virus Production. Processes Talk (3)
2025
Talk
Influenza Vector-Based Defective Interfering Particles for Use as Broad-Spectrum Antiviral and Mucosal Live Vaccine: Construction, Production and in Vivo Efficacy. 34th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)
Talk
Engineered influenza vectors for use as broadly-acting antivirals and live nasal vaccines: design, manufacture and in vivo efficacy. 9th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)
Talk
Expanding Glycoproteomics: Including N-Glycopeptides Bearing Glucuronidated, O-Acetylated or Sulfated N-Glycans in the Analysis of Human Serum Proteins such as Immunoglobulin A. GlycoBioTec 2025, Berlin (Germany) (2025)
Poster (5)
2025
Poster
Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 9th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)
Poster
Genetically engineered influenza defective interfering particles with enhanced immune activation potential and antiviral efficacy in vitro. 9th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)
Poster
Molecular basis for the antiviral activity of the influenza defective interfering particle “OP7”. 34th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)
Poster
The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanisms. 34th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)
Poster
The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanisms. 9th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)
Thesis - PhD (3)
2025
Thesis - PhD
In-Depth N-Glycan Analysis Using a Synergy of Glycomics Technologies: Method Development and Biomedical Applications. Dissertation, Otto-von-Guericke-Universität, Magdeburg (2025)
Thesis - PhD
Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. Dissertation, Otto-von-Guericke-Universität, Magdeburg (2025)
Thesis - PhD
Modeling the Dynamics of Cell Growth, Central Carbon Metabolism and Virus Production in Animal Cells. Dissertation, Otto-von-Guericke-Universität, Magdeburg (2025)